Wei‐Xing Guo
- Hepatology top 0.5%
- Epidemiology top 5%
- Molecular Biology
- Cancer Research top 5%
- Surgery top 10%
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (63 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (33 papers)Liver Disease Diagnosis and Treatment (26 papers)
- Journals
- Nature MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Wei‐Xing Guo
91 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Hepatology 1.5k
- Epidemiology 857
- Molecular Biology 595
- Cancer Research 535
- Surgery 514
Countries citing papers authored by Wei‐Xing Guo
This map shows the geographic impact of Wei‐Xing Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Xing Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Xing Guo more than expected).
Fields of papers citing papers by Wei‐Xing Guo
This network shows the impact of papers produced by Wei‐Xing Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Xing Guo. The network helps show where Wei‐Xing Guo may publish in the future.
Co-authorship network of co-authors of Wei‐Xing Guo
This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Xing Guo. A scholar is included among the top collaborators of Wei‐Xing Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Xing Guo. Wei‐Xing Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 11 | |
| 4 | 20 | |
| 5 | 17 | |
| 6 | 2 | |
| 7 | 12 | |
| 8 | 8 | |
| 9 | 17 | |
| 10 | 9 | |
| 11 | 3 | |
| 12 | 0 | |
| 13 | 60 | |
| 14 | 62 | |
| 15 | 8 | |
| 16 | 84 | |
| 17 | 26 | |
| 18 | 16 | |
| 19 | 132 | |
| 20 | 223 |
About Wei‐Xing Guo
Wei‐Xing Guo is a scholar working on Hepatology, Cancer Research and Epidemiology, having authored 99 papers that have together received 2.4k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (63 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (33 papers) and Liver Disease Diagnosis and Treatment (26 papers). The work is most often cited by research in Hepatology (1.5k citations), Cancer Research (535 citations) and Epidemiology (857 citations). Wei‐Xing Guo has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Shuqun Cheng, Jie Shi, Jie Xue, Mengchao Wu, Wan Yee Lau, Eric C. H. Lai, Xiuping Zhang, Zhenhua Chen, Kang Wang and Shuqun Cheng. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.